Key result
AngioVac thrombectomy achieves substantial right heart thrombus removal in ~60% of patients.
Why the study?
Right heart thrombi can cause substantial morbidity and mortality, especially with pulmonary embolism, but the safety and procedural efficacy of vacuum-assisted thrombectomy with the AngioVac System were not well understood.
Does vacuum-assisted thrombectomy using the AngioVac System safely and effectively remove right heart thrombi?
Observational (n=47)
Yes
Does vacuum-assisted thrombectomy using the AngioVac System safely and effectively remove right heart thrombi?
Vacuum-assisted thrombectomy using the AngioVac System is a feasible and relatively safe minimally invasive option for removing right heart thrombi, achieving significant clot removal in the majority of patients with low rates of major complications.
Answers are grounded in this paper and cite their sources.
May warrant consideration in select patients with right heart thrombi; hypothesis-generating and requires randomized trials for confirmation.
Background: Right heart thrombi can be a source of considerable morbidity and mortality, especially when associated with pulmonary embolism. Methods: To understand the safety and procedural efficacy associated with vacuum-assisted thrombectomy using the AngioVac System (AngioDynamics, Latham, NY, USA) to remove right heart thrombi, we conducted a subanalysis of the Registry of AngioVac Procedures in Detail (RAPID) multicenter registry representing 47 (20.1%) of 234 participants in the registry. Forty-two (89.4%) patients had thrombi located in the right atrium alone, three (6.4%) in the right ventricle alone, and two (4.3%) in both the right atrium and ventricle. Four (8.5%) patients had concomitant caval thrombi, three (6.4%) also had catheter-related thrombi, and one (2.1%) patient had both caval and catheter-related thrombi with their right heart thrombi. Results: Extracorporeal bypass time was less than 1 hour for 39 (83.0%) procedures. Seventy to 100% removal of thrombus was achieved in 59.6% of patients. Estimated blood loss was less than 250 cc for 43 procedures (91.6%). Mean hemoglobin decreased from 10.7 ± 2.2 g/dL preoperatively to 9.6 ± 1.6 g/dL postoperatively. Transfusions were administered for eight procedures (17.0%), with only one (2.1%) patient receiving more than 2 units of blood. Six patients (12.8%) experienced procedure-related adverse events, including three (6.4%) patients who experienced distal emboli and three (6.4%) patients who developed bleeding-related complications. All adverse events resolved prior to discharge. There was one death (2.1%) reported that was not procedure related. Conclusion: Vacuum-assisted thrombectomy can be performed safely in patients with right heart thrombi. ClinicalTrials.gov Identifier: NCT04414332.
No takes yet. Share an insight, caveat, or question.
Moriarty et al. (2022) conducted an observational in Right heart thrombi (n=47). AngioVac System (vacuum-assisted thrombectomy) was evaluated on 70-100% removal of thrombus. Vacuum-assisted thrombectomy using the AngioVac System achieved 70-100% removal of right heart thrombi in 59.6% of patients, with a 12.8% rate of procedure-related adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: